Quality control guidelines for MIC susceptibility testing of NVPPDF-713: a novel peptide deformylase inhibitor

被引:7
作者
Anderegg, TR
Biedenbach, DJ
Jones, RN
机构
[1] JMI Labs Inc, JONES Grp, Beaver Kreek Ctr 345, N Liberty, IA 52317 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] Michigan State Univ, E Lansing, MI 48824 USA
[4] TREK Diagnost, Cleveland, OH USA
[5] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[6] Univ Texas, Houston, TX USA
[7] Univ Washington, Seattle, WA 98195 USA
[8] Strong Mem Hosp, Rochester, NY USA
关键词
D O I
10.1016/s0924-8579(03)00114-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:84 / 86
页数:3
相关论文
共 7 条
[1]   Peptide deformylase as an antibacterial drug target:: Target validation and resistance development [J].
Apfel, CM ;
Locher, H ;
Evers, S ;
Takács, B ;
Hubschwerlen, C ;
Pirson, W ;
Page, MGP ;
Keck, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1058-1064
[2]   Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor [J].
Clements, JM ;
Beckett, RP ;
Brown, A ;
Catlin, G ;
Lobell, M ;
Palan, S ;
Thomas, W ;
Whittaker, M ;
Wood, S ;
Salama, S ;
Baker, PJ ;
Rodgers, HF ;
Barynin, V ;
Rice, DW ;
Hunter, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :563-570
[3]   N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity [J].
Hackbarth, CJ ;
Chen, DZ ;
Lewis, JG ;
Clark, K ;
Mangold, JB ;
Cramer, JA ;
Margolis, PS ;
Wang, W ;
Koehn, J ;
Wu, C ;
Lopez, S ;
Withers, G ;
Gu, H ;
Dunn, E ;
Kulathila, R ;
Pan, SH ;
Porter, WL ;
Jacobs, J ;
Trias, J ;
Patel, DV ;
Weidmann, B ;
White, RJ ;
Yuan, ZY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :2752-2764
[4]  
*NCCLS, 2003, M100S13 NCCLS
[5]  
NCCLS, 2001, M23A2 NCCLS
[6]  
NCCLS, 2003, M7A6 NCCLS
[7]   In vitro activities of peptide deformylase inhibitors against gram-positive pathogens [J].
Wise, R ;
Andrews, JM ;
Ashby, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1117-1118